Neurology Articles

Neurology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Mohamed S et al. – Less than half of patients on LAIR continued treatment for 18 months, a smaller proportion than of those started on most oral first– or second–generation antipsychotics, suggesting that for many patients with schizophrenia improved adherence from this treatment may not be sustained.

Related Articles

Auditory gating deficit to human voices in schizophrenia: A MEG study
Schizophrenia Research, 10/01/09    Relevance Score: 93%

Age at onset and cognition in schizophrenia: meta-analysis
British Journal of Psychiatry, 10/06/09    Relevance Score: 92%

Beyond symptom dimensions: Schizophrenia risk factors for patient groups derived by latent class analysis
Schizophrenia Research, 10/30/09    Relevance Score: 91%

Functional Magnetic Resonance Imaging of Inner Speech in Schizophrenia
Biological Psychiatry, 10/26/09    Relevance Score: 91%

Sensory Processing in Schizophrenia: Neither Simple nor Intact
Schizophrenia Bulletin, 10/19/09    Relevance Score: 91%

Today in Neuro/Psych pharmacology...keeping you current

Antiepileptics in brain metastases: safety, efficacy and impact on life expectancy
Journal of Neuro-Oncology, 12/04/09

Natural history of solitary cerebral cysticercosis cases after albendazole therapy: a longitudinal follow-up study from India
Acta Neurologica Scandinavica, 12/03/09

Effect of Simvastatin on Glioma Cell Proliferation, Migration, and Apoptosis
Neurosurgery, 12/03/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address